New study shows smaller biopharma companies struggle more than larger ones with clinical trial transparency
As clinical trial transparency and the sharing of positive and negative trial results slowly become the norm rather than the exception, a new study published in the BMJ revealed struggles from smaller companies to keep up with their larger rivals when it comes to transparency.
AbbVie, Amgen, Bayer, Merck KGaA/EMD Serono, Novartis, Roche and Takeda all tied for the top spot as the most transparent biopharma companies, the study found.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 113,300+ biopharma pros reading Endpoints daily — and it's free.